NCT02753309 2021-03-19
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
Clinical Trials
4 trialsNCT03298958 2019-06-12
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase 3 Withdrawn
NCT01938573 2017-10-20
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
University of Washington
Phase 1/2 Completed
NCT00375245 2014-01-17
Rapamycin With Grapefruit Juice for Advanced Malignancies
University of Chicago
Phase 1 Completed